John Lepore, ProFound Therapeutics CEO
October 2, 2023 02:51 PM EDTUpdated 04:32 PM
People
Startups

Flag­ship poach­es an­oth­er phar­ma R&D leader as GSK's Lep­ore heads to Pro­Found

Kyle LaHucik

Senior Reporter

John Lep­ore, the for­mer right-hand man for Hal Bar­ron and Tony Wood at GSK, is de­part­ing the UK phar­ma gi­ant to lead a Flag­ship …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times